Awaiting product image

The World Market for Infectious Disease Diagnostic Tests

$3,500.00 – $7,000.00

SKU: KLI5721838 Categories: , , , Pages: 300

Description

The World Market for Infectious Disease Diagnostic Tests

World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.

The market information provided in this report includes the following:

  • Infectious Disease Immunoassay Sales by Region
  • Infectious Disease Immunoassays Market Share
  • Infectious Disease Molecular Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Test Market Shares
  • ID/AST Test Market by Type
  • Infectious Disease ID/AST Sales by Region
  • ID/AST Leader Market Shares
  • Infectious Disease Immunoassays by Type
  • Laboratory Infectious Disease Immunoassays Sales by Disease

The disparity in infectious disease test market growth rates is immediately evident between industrialized, first-world countries with established healthcare systems in North America, Europe and Asia (Japan) and countries of the developing world (China, India, most of Latin America). The developed world is projected to be held to an under-4% aver annual growth rate in terms of infectious disease test sales through 2020. Countries such as China, India and in Latin America, on the other hand, remain in the process of implementing rapid testing as part of infectious disease screening and molecular assays for the diagnosis and treatment of infectious diseases. Even established infectious disease testing tools such as culture ID/AST can expect more robust rates of growth in the developing world as labs update their microbiology testing to automated platforms and increase capacity to handle increased patient volume. A global report, The World Market for Infectious Disease Tests offers geographic breakouts for market categories.

In addition, the report provides market shares for major testing categories and profiles companies. Trends in infectious diseases and in products are discussed. The information contained in this report has been assembled from primary and secondary data. Secondary data was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.

Table of Contents

 

ONE: EXECUTIVE SUMMARY

Introduction

The Globalization of Infectious Diseases

Mounting Threat of Microbial Antibiotic Resistance

Near-Patient Testing

The Global Market for Infectious Disease Tests

ID/AST Market

Infectious Disease Immunoassay Market

Blood Screening Assay Market

Major Conclusions

 

TWO: INTRODUCTION TO INFECTIOUS DISEASES IN HEALTHCARE

Introduction to the Evolving World of Infectious Disease Testing

Public Health Response

Funding Sources

Leading Disease Threats

Leading Infetious Disease Testing Technologies

Point of View

 

THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES

Background

The Globalization of Infectious Diseases

Globalization Through Trade and Travel

Disease Burdens in Developing World

Vaccines

Mounting Threat of Microbial Antibiotic Resistance

Near-Patient Testing

New Technology Platforms in Infectious Disease Testing

Real-Time PCR

Alternative Nucleic Acid Amplification Methods

Loop-mediated isothermal amplification (LAMP)

Nicking Enzyme Amplification Reaction (NEAR)

Strand Displacement Amplification (SDA)

Helicase Dependent Amplification (HDA)

Nucleic Acid Sequence-Based Amplification (NASBA

Transcription-mediated amplification (TMA)

Sequencing

Mass Spectrometry

Flow Cytometry

Conclusions

 

FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET

Background

The World Market for Infectious disease Tests

Infectious Disease Test Markets – ID/AST, Immunoassays, Molecular Assays

Major Competitors in the Global Infectious Disease Test Market

Market-Leading Infectious Diseases

 

FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING

Background

Liquid Microbiology and ID/AST Automation

Market Analysis

Regional Breakout

Market Share

Rapid Tests

Microbial Identification and Antimicrobial Susceptibility Systems

Chromogenic Media

Blood Culture

Vendor Developments in Blood Culture ID Testing

Market Outlook for ID/AST Testing

 

SIX: THE MARKET FOR IMMUNOASSAYS

Background

Sepsis Serology

Hepatitis

HIV

Mycology

Parasitology

Respiratory

ToRCH

Sexually Transmitted Diseases (STDs)

Regional Breakout

Market Outlook for Immunoassay Infectious Disease Testing

 

SEVEN: THE MARKET FOR MOLECULAR ASSAYS

Background

Market Analysis

HAI Market

HIV Market

Hepatitis Market

Chlamydia/Gonorrhea (CT/NG)

HPV

Respiratory

Mycobacteria/TB

Other

CT/NG, HPV and Sexual Health / Women’s Health

Healthcare-Acquired Infections (HAIs) / Antimicrobial Resistance (AMR)

HIV

Respiratory

Market Outlook for Molecular Infectious Disease Testing

 

EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET

Commonly Tested Pathogens in Blood Screening

Market Analysis by Type

Vendor Market Share

Immunoassays

Nucleic Acid Tests (NATs)

Nucleic Acid Test Introductions and Innovations

 

NINE: COMPANY PROFILES

Abbott Diagnostics

Alere

Beckman Coulter (Danaher)

Becton, Dickinson & Co. (BD)

bioMérieux

Bio-Rad Laboratories

Cepheid

Chembio Diagnostic Systems

Copan Diagnostics

DiaSorin

Molecular

Blood Banking

Grifols

Blood Screening (Molecular PROCLEIX Tests)

Hologic

Molecular Cytology / Histology (HPV)

Other Molecular (STIs, HIV, HCV, TB, Respiratory)

Microbiology (AccuProbe Molecular Culture ID Tests)

Blood Screening (Molecular PROCLEIX Tests)

Meridian Bioscience

OraSure Technologies

Ortho-Clinical Diagnostics

QIAGEN

Molecular Diagnostics

Immunoassays

Quidel Corporation

Roche Diagnostics

Siemens Healthcare Diagnostics

Thermo Fisher Scientific

Trinity Biotech

 

LIST OF EXHIBITS

 

ONE: EXECUTIVE SUMMARY

Figure 1-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year(30 EEA Member Countries/2004-2013) – Methicillin Resistant S. aureus (MRSA)

Figure 1-2: Worldwide Infectious Disease Test Market by Region

Table 1-2: Worldwide Infectious Disease Test Market by Region/Country North America, Western Europe (EU), Japan, China, India, Latin America,Rest of the World (ROW) (2015-2020)

Table 1-3: Worldwide Infectious Disease Test Market by Test Segment – LaboratoryImmunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020)

 

THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES

Table 3-1: Infectious Diseases of Globalization and Their Drivers

Table 3-2: Disease Preventable Vaccines in 2015

Table 3-3: Preventive Vaccines in Development for Infectious Diseases (2015)

Figure 3-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – E. coli Resistance to Third-Generation Cephalosporins

Figure 3-2: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – K. pneumoniae Multidrug Resistance to Third-Generation Cephalosporins, Fluoroquinolones and Aminoglycosides

Figure 3-3: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – Methicillin Resistant S. aureus (MRSA)

Table 3-4: Selected Advanced Antibiotic Resistance Tests

Table 3-5: Selected Antibiotic Resistance Facts (CDC)

Table 3-6: Selected Advanced Near-Patient Infectious Disease Testing Platforms

Table 3-7: Selected Microorganisms and Their Associated Diseases

Table 3-8: Selected Isothermal Amplification Methods and Platform Examples

Table 3-9: Selected Next Generation Sequencers for Infectious Disease Applications

Table 3-10: Selected Infectious Disease Sequencing Innovations

Table 3-11: Selected Mass Spectrometry Microbiology Platforms

Table 3-12: Selected Flow Cytometry Infectious Disease Applications

 

FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET

Table 4-1: Worldwide Infectious Disease Test Market by Region/Country – North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020)

Table 4-2: Worldwide Infectious Disease Test Market by Test Segment – Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions)

Table 4-3: Global Infectious Disease Test Market Shares – Abbott Diagnostics, Alere, Beckman Coulter, BD, bioMérieux, Bio-Rad Labs, Cepheid, DiaSorin, Grifols, Hologic, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Others (%)

Table 4-4: Worldwide Infectious Disease Test Market by Major Diseases – HAI / AMR, Hepatitis, HIV, Respiratory, STDs / Women’s Health, Other Infectious Diseases (2015) ($ millions)

 

FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING

Table 5-1: Microbiology Sample/Specimen Types Ranked by Average Volume

Table 5-2: Worldwide ID/AST Sales by Segment – Panels and Reagents, Blood Culture, Chromogenic Media, Rapid Micro (2015-2020) ($ millions)

Table 5-3: Worldwide ID/AST Sales by Region – North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions)

Table 5-4: ID/AST Leader Market Shares – BD, Beckman Coulter, bioMérieux, Thermo Fisher Scientific, Others

Table 5-5: Selected ID/AST System Innovations

Table 5-6: Selected Chromogenic Media Innovations and Launches

Table 5-7: Selected Blood Culture Innovations and Launches

 

SIX: THE MARKET FOR IMMUNOASSAYS

Table 6-1: Selected Sepsis Serology Innovations

Table 6-2: Worldwide Infectious Disease Immunoassay Sales by Segment – Lab-Based, Rapid / POC (2015-2020) ($ millions)

Table 6-3: Worldwide Infectious Disease Immunoassay Sales by Region – North America, Western Europe, Japan, China, India, Latin America,

ROW (2015-2020) ($ millions)

Table 6-4 Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Trinity Biotech, Others

Table 6-5: Laboratory Infectious Disease Immunoassays Sales by Disease or Pathogen – Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases (STDs), ToRCH, Others (2015)

Table 6-6: Selected Laboratory Infectious Disease Immunoassay Innovations

Table 6-7: CLIA-Waived Infectious Disease Tests and Analytes

Table 6-8: Rapid Infectious Disease Immunoassays Sales by Disease or Pathogen – C. difficile, E. coli, H. pylori, Hepatitis, HIV, Influenza, Malaria, Strep A, STDs, Others (2015)

Table 6-9: Selected Rapid Infectious Disease Immunoassay Innovations

 

SEVEN: THE MARKET FOR MOLECULAR ASSAYS

Table 7-1: Selected Moderate and Waived Complexity Molecular Infectious Disease Testing Platforms

Table 7-2: Worldwide Molecular Infectious Disease Assay Sales by Disease Area – CT/NG, HAIs, Hepatitis, HIV, HPV, Mycobacteria/TB,

Respiratory, Others (2015-2020)

Table 7-3 bioMérieux, Cepheid, Hologic, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Others

Table 7-4: Selected Molecular Sexual Health and Women’s Health Test Introductions and Innovations

Table 7-5: Selected Molecular Healthcare-Acquired Infection (HAI) / Antimicrobial Resistance (AMR) Test Introductions and Innovations

Table 7-6: Selected Molecular Hepatitis Test Introduction and Innovations

Table 7-7: Selected Molecular HIV Test Introduction and Innovations

Table 7-8: Selected Molecular Respiratory Infection Test Introduction and Innovations 178

 

EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET

Table 8-1: Commonly Tested Pathogens in Blood Screening

Table 8-2: Worldwide Infectious Disease Blood Screening Test Sales – Immunoassays and Nucleic Acid Tests (NATs) (2015-2020) ($ millions)

Table 8-3: Infectious Disease Blood Screening Test Market Shares – Abbott Diagnostics, DiaSorin, Grifols, Hologic, Ortho-Clinical Diagnostics, Roche Diagnostics, Others

Table 8-4: Selected Blood Screening Immunoassay Introductions and Innovations Nucleic Acid Tests (NATs)

Table 8-5: Selected Blood Screening Nucleic Acid Test Introductions and Innovations..

 

NINE: COMPANY PROFILES

Table 9-2: Alere Revenue (2011-2014)

Table 9-3: Beckman Coulter Revenue (2011-2014)

Table 9-4: Becton, Dickinson & Co. (BD) Revenue (FY 2011-2014)

Table 9-5: bioMérieux Revenue (2011-2014)

Table 9-6: Bio-Rad Laboratories Revenue (2011-2014)

Table 9-7: Cepheid Revenue (2011-2014)

Table 9-8: Chembio Diagnostics Systems Revenue (2011-2014)

Table 9-9: DiaSorin Revenue (2011-2014)

Table 9-10: Grifols Revenue (2011-2014)

Table 9-11: Hologic Revenue (FY 2011-2014)

Table 9-12: Meridian Bioscience Revenue (2011-2014)

Table 9-13: OraSure Technologies Revenue (2011-2014)

Table 9-14: Ortho-Clinical Diagnostics Revenue (2011-2014)

Table 9-15: QIAGEN Revenue (2011-2014)

Table 9-16: Quidel Corporation Revenue (2011-2014)

Table 9-17: Roche Diagnostics Revenue (2011-2014)

Table 9-18: Siemens Healthcare Diagnostics Revenue (FY 2011-2014)

Table 9-19: Thermo Fisher Scientific Revenue (2011-2014)

Table 9-20: Trinity Biotech Revenue (2011-2014)

 

Related products

Mergers and Acquisitions in the IVD Market, October 2015Roche Diagnostics: Company Profile